Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

6 Countries

Phase III

Phase I (FiH)

Phase III: 1 Phase I (FiH): 1

Indications tested

2 total

A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting

2025-521012-18-00 Phase III 6 countries Avidity Biosciences Inc.
Phase 1/2 Study of AOC 1020 in Adults with Facioscapulohumeral Muscular Dystrophy (FSHD) Ended

2022-502096-32-00 Phase I (FiH) 2 countries Avidity Biosciences Inc.

Showing 1–2 of 2 trials